Who makes the decision regarding the treatment of clinically localized prostate cancer-the patient or physician?

被引:29
|
作者
Song, Lixin [1 ,2 ]
Chen, Ronald C. [2 ,3 ,4 ]
Bensen, Jeannette T. [2 ,5 ]
Knafl, George J. [1 ]
Nielsen, Matthew E. [6 ]
Farnan, Laura [2 ]
Wallen, Eric M. [6 ]
Mishel, Merle [1 ,2 ]
Pruthi, Raj S. [6 ]
Mohler, James L. [2 ,7 ]
Godley, Paul A. [2 ,4 ,5 ,8 ]
机构
[1] Univ N Carolina, Sch Nursing, Adult & Geriatr Hlth Div, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Dept Radiat Oncol, Sch Med, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC 27599 USA
[5] Univ N Carolina, Dept Epidemiol, Sch Publ Hlth, Chapel Hill, NC 27599 USA
[6] Univ N Carolina, Div Urol Surg, Sch Med, Chapel Hill, NC 27599 USA
[7] Roswell Pk Canc Inst, Dept Urol, Buffalo, NY 14263 USA
[8] Univ N Carolina, Div Hematol Oncol, Sch Med, Chapel Hill, NC 27599 USA
关键词
decision-making; localized prostate cancer; subjective-affective factors; cancer aggressiveness; age; QUALITY-OF-LIFE; RADICAL PROSTATECTOMY; CARE NEEDS; MEN; PARTICIPATION; INFORMATION; REGRET; INTERVENTION; PREFERENCES; INVOLVEMENT;
D O I
10.1002/cncr.27738
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: The current study examined how patients' sociodemographic, cancer-related, and subjective affective factors impacted their role in treatment decision-making. METHODS: The patient sample (N = 788) was taken from a prospective follow-up study of a population-based cohort. Participants included 343 African American and 445 Caucasian-American patients with clinically localized prostate cancer. Multinomial logistic regression was used to investigate relations between the explanatory variables and the nominal 3-level decision-making variable: patient-only, patient-physician shared, and physician-only. RESULTS: Approximately 41% of patients reported patient-only decision-making, 45% reported shared decision-making, and 13% reported physician-only decision-making. The odds of patient-only over physician-only decision-making were greater for younger men (vs those aged = 65 years) (odds ratio [OR], 1.68; 95% confidence interval [95% CI], 1.03-2.74), and were less for men with high (vs low) cancer aggressiveness (OR,0.29; 95% CI, 0.15-0.55). The odds of shared over physician-only decision-making were less for men with high (vs low) cancer aggressiveness (OR, 0.40; 95% CI, 0.22-0.73). Greater odds of patient-only and shared decision-making also were found to be associated with greater concerns about the physical impact of treatment and having enough time for decision-making and lower scores of receiving advice from others. CONCLUSIONS: The findings of the current study indicate that, to facilitate a more patient-oriented decision-making process regarding treatment in those with clinically localized prostate cancer, clinicians need to tailor their interventions according to patient age and cancer aggressiveness, help reduce patient concerns and misconceptions regarding the physical impact of treatments, allow sufficient time for patients to consider treatment options, and assist patients in balancing advice and information received from different sources. Cancer 2013. (c) 2012 American Cancer Society.
引用
收藏
页码:421 / 428
页数:8
相关论文
共 50 条
  • [1] WHO MAKES THE DECISION REGARDING TREATMENT FOR LOCALIZED PROSTATE CANCER, PATIENT OR PHYSICIAN? RESULTS FROM A POPULATION-BASED STUDY
    Song, Lixin
    Kurpad, Raj
    Udell, Ian
    Bensen, Jeannette
    Smith, Angela
    Nielsen, Matthew
    Wallen, Eric
    Woods, Michael
    Pruthi, Raj
    Mohler, James
    [J]. JOURNAL OF UROLOGY, 2012, 187 (04): : E138 - E139
  • [2] A decision analysis for treatment of clinically localized prostate cancer
    Kattan, MW
    Cowen, ME
    Miles, BJ
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1997, 12 (05) : 299 - 305
  • [3] A Decision Analysis for Treatment of Clinically Localized Prostate Cancer
    Michael W. Kattan
    Mark E. Cowen
    Brian J. Miles
    [J]. Journal of General Internal Medicine, 1997, 12 : 299 - 305
  • [4] Physician Visits Prior to Treatment for Clinically Localized Prostate Cancer
    Jang, Thomas L.
    Bekelman, Justin E.
    Liu, Yihai
    Bach, Peter B.
    Basch, Ethan M.
    Elkin, Elena B.
    Zelefsky, Michael J.
    Scardino, Peter T.
    Begg, Colin B.
    Schrag, Deborah
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2010, 170 (05) : 440 - 450
  • [5] Questioning decision analysis for treatment of clinically localized prostate cancer
    Daniel J. Cher
    Michael W. Kattan
    Mark E. Cowen
    Brian J. Miles
    [J]. Journal of General Internal Medicine, 1997, 12 : 659 - 659
  • [6] Questioning decision analysis for treatment of clinically localized prostate cancer
    Cher, DJ
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1997, 12 (10) : 659 - 659
  • [7] Diagnosis prostate cancer: who makes the treatment decision and which treatment is selected? Opinion survey in a prostate cancer patient support group
    Schnell, D.
    Fiebrandt, H.
    Weissbach, L.
    [J]. UROLOGE, 2012, 51 (02): : 238 - 241
  • [8] PATIENT PARTICIPATION IN TREATMENT DECISION MAKING FOR LOCALIZED PROSTATE CANCER.
    Song, Lixin
    Bai, Jinbing
    Tole, Mark
    Mishel, Merle
    Bailey, Chip
    [J]. ONCOLOGY NURSING FORUM, 2015, 42 (02) : E231 - E231
  • [9] A DECISION-ANALYSIS OF ALTERNATIVE TREATMENT STRATEGIES FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    FLEMING, C
    WASSON, JH
    ALBERTSEN, PC
    BARRY, MJ
    WENNBERG, JE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (20): : 2650 - 2658
  • [10] RATIONALE FOR THE TREATMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER
    SCARDINO, PT
    [J]. EUROPEAN UROLOGY, 1995, 27 : 17 - 20